Limitations and Challenges in the Stability of Cysteamine Eye Drop Compounded Formulations
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Limitations and Challenges in the Stability of Cysteamine Eye Drop Compounded Formulations
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 15, Issue 1, Pages 2
Publisher
MDPI AG
Online
2021-12-21
DOI
10.3390/ph15010002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Challenges for cysteamine stabilization, quantification, and biological effects improvement
- (2020) Carla Atallah et al. Journal of Pharmaceutical Analysis
- Long-term follow-up of cystinosis patients treated with 0.55% cysteamine hydrochloride
- (2020) Hong Liang et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Recent Research in Ocular Cystinosis: Drug Delivery Systems, Cysteamine Detection Methods and Future Perspectives
- (2020) Ana Castro-Balado et al. Pharmaceutics
- Nephropathic Cystinosis: Symptoms, Treatment, and Perspectives of a Systemic Disease
- (2018) Sören Bäumner et al. Frontiers in Pediatrics
- Novel approaches for improving stability of cysteamine formulations
- (2018) Phillip Dixon et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Effects of long-term cysteamine treatment in patients with cystinosis
- (2017) Gema Ariceta et al. PEDIATRIC NEPHROLOGY
- Effect of pH and penetration enhancers on cysteamine stability and trans-corneal transport
- (2016) Silvia Pescina et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Preformulation of cysteamine gels for treatment of the ophthalmic complications in cystinosis
- (2016) Barbara McKenzie et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Controversies and research agenda in nephropathic cystinosis: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
- (2016) Craig B. Langman et al. KIDNEY INTERNATIONAL
- Synergistic Cysteamine Delivery Nanowafer as an Efficacious Treatment Modality for Corneal Cystinosis
- (2016) Daniela C. Marcano et al. MOLECULAR PHARMACEUTICS
- Gelatin-based particulate systems in ocular drug delivery
- (2015) Rania M. Hathout et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- A new gel formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis: The Cystadrops OCT-1 study
- (2014) Antoine Labbé et al. MOLECULAR GENETICS AND METABOLISM
- Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults
- (2011) Albane Brodin-Sartorius et al. KIDNEY INTERNATIONAL
- Activation energies for the decomposition of pharmaceuticals and their application to predicting hydrolytic stability in drug discovery
- (2010) Philip A. MacFaul et al. MedChemComm
- Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis
- (2008) S BOZDAG et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More